Home » Topics » Regulatory

Regulatory
RSS

E.U. approval of irbesartan for renal disease in hypertensive and type 2 diabetes patients

July 1, 2002

Phase III program initiated for Actiza

June 28, 2002

FDA approves injectable Geodon for schizophrenia

June 27, 2002

Nonapprovable letter issued for Casodex in early prostate cancer

June 27, 2002

Metformin XT is equivalent to immediate-release metformin in the treatment of type 2 diabetes

June 27, 2002

Ethypharm and Viatris collaborate on Flashtab formulation of tramadol

June 25, 2002

Australia first to approve Xolair

June 21, 2002

FDA approves Celebrex labeling changes

June 18, 2002

Japanese approval obtained for Elaspol

June 18, 2002

Extina enters phase III for seborrheic dermatitis

June 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...